Xencor
XNCRAlgoritmens signaler
- ›Starkt 3m-momentum (+94.3%)
- ›Starkt 6m-momentum (+102.0%)
- ›Starkt 12m-momentum (+156.3%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›Hög volatilitet (68% årlig)
- ›+179% från 52v-botten
- ›Ökad handelsvolym (+31%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsXencor (XNCR) Holds Near $23.84 as Shares Consolidate Between Key Levels - Chart Pattern Alerts - dars.gov.et
14 h sedanXencor (XNCR) Holds Near $23.84 as Shares Consolidate Between Key Levels - Chart Pattern Alerts dars.gov.et
dars.gov.etXencor (XNCR) Heads To Cantor Conference With Fair Value Still In Focus - simplywall.st
1 d sedanXencor (XNCR) Heads To Cantor Conference With Fair Value Still In Focus simplywall.st
simplywall.stXencor (NASDAQ:XNCR) Stock Price Down 9% - What's Next? - MarketBeat
2026-08-28Xencor (NASDAQ:XNCR) Stock Price Down 9% - What's Next? MarketBeat
MarketBeatXencor Reports Second Quarter 2026 Financial Results
2026-08-05Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the se
XencorBusiness WireXENCOR ($XNCR) Releases Q2 2026 Earnings - Quiver Quantitative
2026-08-05XENCOR ($XNCR) Releases Q2 2026 Earnings Quiver Quantitative
Quiver QuantitativeXencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter
2026-07-29Xencor, Inc. (NASDAQ:XNCR) (“Xencor”), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced its agreement wi
XencorBusiness WireXencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock? - finance.yahoo.com
2026-07-20Xencor (XNCR) Soars 16.9%: Is Further Upside Left in the Stock? finance.yahoo.com
finance.yahoo.comXencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
2026-07-17Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that results from a Phase 1
XencorBusiness WireXencor advances 17% after revealing ESMO 2026 oral presentation slot (XNCR:NASDAQ) - Seeking Alpha
2026-07-17Xencor advances 17% after revealing ESMO 2026 oral presentation slot (XNCR:NASDAQ) Seeking Alpha
Seeking AlphaXNCR Forecast — Price Target — Prediction for 2027 - TradingView
2026-06-25XNCR Forecast — Price Target — Prediction for 2027 TradingView
TradingViewXNCR - Xencor Inc Stock Price and Quote - Finviz
2026-05-28XNCR - Xencor Inc Stock Price and Quote Finviz
FinvizXencor Reports First Quarter 2026 Financial Results
2026-05-06Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the fi
XencorBusiness WireXencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW
2026-05-04Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported final results from the Phase
XencorBusiness WireXencor Announces Change to Ultomiris® Royalty Revenue Forecast
2026-03-04Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that Alexion Pharmaceutical
XencorBusiness WireXencor Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-25Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the fo
XencorBusiness WireXencor to Participate at Upcoming Investor Conferences
2026-02-23Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management wil
XencorBusiness Wire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.